Cargando…

The “histological replacement growth pattern” represents aggressive invasive behavior in liver metastasis from pancreatic cancer

BACKGROUND: In the case of liver metastasis (LM), tumors showing the replacement growth pattern (RGP), in which metastatic cells infiltrate and replace hepatocytes with minimal desmoplastic reaction and inflammatory cell infiltration, associate with a poor prognosis. The heterogeneity, frequency, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Kazuo, Mitsunaga, Shuichi, Kojima, Motohiro, Suzuki, Hidetaka, Irisawa, Ai, Takahashi, Hideaki, Sasaki, Mitsuhito, Hashimoto, Yusuke, Imaoka, Hiroshi, Ohno, Izumi, Ikeda, Masafumi, Akimoto, Tetsuo, Ochiai, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196051/
https://www.ncbi.nlm.nih.gov/pubmed/32135041
http://dx.doi.org/10.1002/cam4.2954
Descripción
Sumario:BACKGROUND: In the case of liver metastasis (LM), tumors showing the replacement growth pattern (RGP), in which metastatic cells infiltrate and replace hepatocytes with minimal desmoplastic reaction and inflammatory cell infiltration, associate with a poor prognosis. The heterogeneity, frequency, and prognostic value of the RGP in LM from pancreatic cancer (PCa) are not well known. METHODS: In the circumference of treatment‐naïve resected LMs from patients with PCa, the heterogeneity of the GP was assessed. Next, the clinicopathological features of LMs showing the RGP in needle biopsy specimens were investigated in patients with treatment‐naïve advanced PCa. RESULTS: Thirteen of the 14 (93%) in all resected LMs and 7 of the 9 (78%) in RGP component GP in resected LMs showed homogeneous GP. A RGP was found in 50% of the needle biopsy specimens of LMs obtained from 107 patients. The median overall survival times in the RGP group and non‐RGP group were 3.6 and 10.4 months. Multivariate analysis identified RGP as an independent poor prognostic factor. Median value of CD8 positive percentage in RGP was lower than that in non‐RGP (0.75 vs 1.46, P = .04). Median overall survival times in low CD8 groups tend to be shorter than those in high CD8 group (8.2 vs 4.2 months). CONCLUSION: Most LMs from PCa show a homogeneous GP. The RGP was observed in about a half of the LMs from PCa patients, and was identified as a poor prognostic factor.